Vitrectomy (25G) in a 69-year-old patient with vitreomacular traction syndrome in diabetic retinopathy after branch retinal vein occlusion

[1] Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, Sadda SR, Sebag J, Spaide RF, Stalmans P. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013; 120(12):2611–2619. DukerJS KaiserPK BinderS de SmetMD GaudricA ReichelE SaddaSR SebagJ SpaideRF StalmansP The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole Ophthalmology 2013 120 12 2611 2619 Search in Google Scholar

[2] Panozzo G, Cicinelli MV, Augustin AJ, Battaglia Parodi M, Cunha-Vaz J, Guarnaccia G, Kodjikian L, Jampol LM, Jünemann A, Lanzetta P, et al. An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification. Eur J Ophthalmol. 2020; 30(1):8–18. PanozzoG CicinelliMV AugustinAJ Battaglia ParodiM Cunha-VazJ GuarnacciaG KodjikianL JampolLM JünemannA LanzettaP An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification Eur J Ophthalmol 2020 30 1 8 18 Search in Google Scholar

[3] Hsieh YT, Yang CM. Vitreomacular traction in diabetic retinopathy. Jpn J Ophthalmol. 2024; 68(1):12–18. HsiehYT YangCM Vitreomacular traction in diabetic retinopathy Jpn J Ophthalmol 2024 68 1 12 18 Search in Google Scholar

[4] Johnson MW. Posterior vitreous detachment: evolution and complications of its early stages. Am J Ophthalmol. 2010; 149(3):371–82. JohnsonMW Posterior vitreous detachment: evolution and complications of its early stages Am J Ophthalmol 2010 149 3 371 82 Search in Google Scholar

[5] Rios Gonzalez R, Villegas VM, Blasini M. Bilateral vitreomacular traction syndrome associated with topical pilocarpine 1% ophthalmic solution. Am J Ophthalmol Case Rep. 2023; 13;30:101834. Rios GonzalezR VillegasVM BlasiniM Bilateral vitreomacular traction syndrome associated with topical pilocarpine 1% ophthalmic solution Am J Ophthalmol Case Rep 2023 13 30 101834 Search in Google Scholar

[6] Charbonnel J, Glacet-Bernard A, Korobelnik JF, Nyouma-Moune E, Pournaras CJ, Colin J, Coscas G, Soubrane G. Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol. 2004; 242(3):223–8. CharbonnelJ Glacet-BernardA KorobelnikJF Nyouma-MouneE PournarasCJ ColinJ CoscasG SoubraneG Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment Graefes Arch Clin Exp Ophthalmol 2004 242 3 223 8 Search in Google Scholar

[7] Johnson TM, Vaughn CW, Glaser BM. Branch retinal vein occlusion associated with vitreoretinal traction. Can J Ophthalmol. 2006; 41(5):600–2. JohnsonTM VaughnCW GlaserBM Branch retinal vein occlusion associated with vitreoretinal traction Can J Ophthalmol 2006 41 5 600 2 Search in Google Scholar

[8] Ascaso FJ, Padgett E, Núñez E, Villén L, Grzybowski A, Cristóbal JA. Branch retinal vein occlusion and vitreovascular traction: a preliminary spectral domain OCT case-control study. Graefes Arch Clin Exp Ophthalmol. 2014; 252(3):375–81. AscasoFJ PadgettE NúñezE VillénL GrzybowskiA CristóbalJA Branch retinal vein occlusion and vitreovascular traction: a preliminary spectral domain OCT case-control study Graefes Arch Clin Exp Ophthalmol 2014 252 3 375 81 Search in Google Scholar

[9] Hikichi T, Yoshida A, Trempe CL. Course of vitreomacular traction syndrome. Am J Ophthalmol. 1995; 119(1):55–61. HikichiT YoshidaA TrempeCL Course of vitreomacular traction syndrome Am J Ophthalmol 1995 119 1 55 61 Search in Google Scholar

[10] Nawrocka ZA, Nawrocka Z, Nawrocki J. Swept-Source Optical Coherence Tomography Angiography in Vitreomacular Traction Syndrome. J Vitreoretin Dis. 2021; 6(1):31–39. NawrockaZA NawrockaZ NawrockiJ Swept-Source Optical Coherence Tomography Angiography in Vitreomacular Traction Syndrome J Vitreoretin Dis 2021 6 1 31 39 Search in Google Scholar

[11] Petrou P, Chalkiadaki E, Errera MH, Liyanage S, Wickham L, Papakonstantinou E, Karamaounas A, Kanakis M, Georgalas I, Kandarakis S, et al. Factors associated with the clinical course of vitreomacular traction. J Ophthalmol. 2020; 2020:9457670. PetrouP ChalkiadakiE ErreraMH LiyanageS WickhamL PapakonstantinouE KaramaounasA KanakisM GeorgalasI KandarakisS Factors associated with the clinical course of vitreomacular traction J Ophthalmol 2020 2020 9457670 Search in Google Scholar

[12] Haines NR, Manoharan N, Olson JL, D’Alessandro A, Reisz JA. Metabolomics analysis of human vitreous in diabetic retinopathy and rhegmatogenous retinal detachment. J Proteome Res. 2018; 17(7):2421–2427. HainesNR ManoharanN OlsonJL D’AlessandroA ReiszJA Metabolomics analysis of human vitreous in diabetic retinopathy and rhegmatogenous retinal detachment J Proteome Res 2018 17 7 2421 2427 Search in Google Scholar

[13] Hu Huang; Pentosephosphate pathway and diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2023; 64(8):1823. HuHuang Pentosephosphate pathway and diabetic retinopathy Invest. Ophthalmol. Vis. Sci. 2023 64 8 1823 Search in Google Scholar

[14] Lin A, Xia H, Zhang A, Liu X, Chen H. Vitreomacular interface disorders in proliferative diabetic retinopathy: An optical coherence tomography study. J Clin Med. 2022; 11(12):3266. LinA XiaH ZhangA LiuX ChenH Vitreomacular interface disorders in proliferative diabetic retinopathy: An optical coherence tomography study J Clin Med 2022 11 12 3266 Search in Google Scholar

[15] Li X, Luo X, Lu X, Duan J, Xu G. Metabolomics study of diabetic retinopathy using gas chromatography-mass spectrometry: A comparison of stages and subtypes diagnosed by Western and Chinese medicine. Mol Biosyst. 2011; 7(7):2228–37. LiX LuoX LuX DuanJ XuG Metabolomics study of diabetic retinopathy using gas chromatography-mass spectrometry: A comparison of stages and subtypes diagnosed by Western and Chinese medicine Mol Biosyst 2011 7 7 2228 37 Search in Google Scholar

[16] Klaassen I, van Geest RJ, Kuiper EJ, van Noorden CJ, Schlingemann RO. The role of CTGF in diabetic retinopathy. Exp Eye Res. 2015; 133:37–48. KlaassenI van GeestRJ KuiperEJ van NoordenCJ SchlingemannRO The role of CTGF in diabetic retinopathy Exp Eye Res 2015 133 37 48 Search in Google Scholar

[17] Hayashi K, Sato T, Manabe SI, Hirata A, Yoshimura K. Posterior vitreous detachment in patients with diabetes mellitus. Jpn J Ophthalmol. 2020; 64(2):187–195. HayashiK SatoT ManabeSI HirataA YoshimuraK Posterior vitreous detachment in patients with diabetes mellitus Jpn J Ophthalmol 2020 64 2 187 195 Search in Google Scholar

[18] Browning DJ, Stewart MW, Lee C. Diabetic macular edema: Evidence-based management. Indian J Ophthalmol. 2018; 66(12):1736–1750. BrowningDJ StewartMW LeeC Diabetic macular edema: Evidence-based management Indian J Ophthalmol 2018 66 12 1736 1750 Search in Google Scholar

[19] Sorour OA, Levine ES, Baumal CR, Elnahry AG, Braun P, Girgis J, Waheed NK. Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods. Surv Ophthalmol. 2023; 68(2):147–174. SorourOA LevineES BaumalCR ElnahryAG BraunP GirgisJ WaheedNK Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods Surv Ophthalmol 2023 68 2 147 174 Search in Google Scholar

[20] Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A, Lopez-Galvez M, Navarro-Gil R, Verges R. Diabetic macular edema pathophysiology: Vasogenic versus inflammatory. J Diabetes Res. 2016;2016:2156273. Romero-ArocaP Baget-BernaldizM Pareja-RiosA Lopez-GalvezM Navarro-GilR VergesR Diabetic macular edema pathophysiology: Vasogenic versus inflammatory J Diabetes Res 2016 2016 2156273 Search in Google Scholar

[21] Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015; 372(13):1193–203. Diabetic Retinopathy Clinical Research Network WellsJA GlassmanAR AyalaAR JampolLM AielloLP AntoszykAN Arnold-BushB BakerCW BresslerNM BrowningDJ Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema N Engl J Med 2015 372 13 1193 203 Search in Google Scholar

[22] Rotsos TG, Moschos MM. Cystoid macular edema. Clin Ophthalmol. 2008; 2(4):919–30. RotsosTG MoschosMM Cystoid macular edema Clin Ophthalmol 2008 2 4 919 30 Search in Google Scholar

[23] Wilson DS, Pinto AM, Gupta RR. Pars plana vitrectomy for vitreomacular traction resulting in persistent postoperative loculated foveal subretinal fluid. J VitreoretinDis. 2023; 7(6):552–556. WilsonDS PintoAM GuptaRR Pars plana vitrectomy for vitreomacular traction resulting in persistent postoperative loculated foveal subretinal fluid J VitreoretinDis 2023 7 6 552 556 Search in Google Scholar

[24] Kumar N, Al Kandari J, Al Sabti K, Wani VB. Partial-thickness macular hole in vitreomacular traction syndrome: a case report and review of the literature. J Med Case Rep. 2010; 4:7. KumarN Al KandariJ Al SabtiK WaniVB Partial-thickness macular hole in vitreomacular traction syndrome: a case report and review of the literature J Med Case Rep 2010 4 7 Search in Google Scholar

[25] Tayyab M, Iqbal K, Abid MA, Ur Rahman F, Tayyab HA. Surgical outcome of vitreomacular traction associated with macular hole. Cureus. 2022; 14(12):e32620. TayyabM IqbalK AbidMA Ur RahmanF TayyabHA Surgical outcome of vitreomacular traction associated with macular hole Cureus 2022 14 12 e32620 Search in Google Scholar

[26] Joondeph BC, Willems P, Raber T, Duchateau L, Markoff J. Prognostic factors associated with ocriplasmin efficacy for the treatment of symptomatic vitreomacular adhesion and full-thickness macular hole: Analysis from four studies. J Ophthalmic Vis Res. 2021; 16(1):42–55. JoondephBC WillemsP RaberT DuchateauL MarkoffJ Prognostic factors associated with ocriplasmin efficacy for the treatment of symptomatic vitreomacular adhesion and full-thickness macular hole: Analysis from four studies J Ophthalmic Vis Res 2021 16 1 42 55 Search in Google Scholar

[27] Bennison C, Stephens S, Lescrauwaet B, Van Hout B, Jackson TL. Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole. J Mark Access Health Policy. 2016; 4. BennisonC StephensS LescrauwaetB Van HoutB JacksonTL Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole J Mark Access Health Policy 2016 4 Search in Google Scholar

[28] Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S, Haller JA; MIVI-TRUST Study Group. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012; 367(7):606–15. StalmansP BenzMS GandorferA KampikA GirachA PakolaS HallerJA MIVI-TRUST Study Group Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes N Engl J Med 2012 367 7 606 15 Search in Google Scholar

[29] Jackson TL, Haller J, Blot KH, Duchateau L, Lescrauwaet B. Ocriplasmin for treatment of vitreomacular traction and macular hole: A systematic literature review and individual participant data meta-analysis of randomized, controlled, double-masked trials. Surv Ophthalmol. 2022; 67(3):697–711. JacksonTL HallerJ BlotKH DuchateauL LescrauwaetB Ocriplasmin for treatment of vitreomacular traction and macular hole: A systematic literature review and individual participant data meta-analysis of randomized, controlled, double-masked trials Surv Ophthalmol 2022 67 3 697 711 Search in Google Scholar